Login / Signup

Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study.

Jin-Ji YangYan ZhangLin WuJie HuZhe-Hai WangJing-Hua ChenYun FanGen LinQi-Ming WangYu YaoJun ZhaoYuan ChenJian FangYong SongWei ZhangYing ChengRen-Hua GuoXing-Ya LiHe-Peng ShiWei-Zhe XueDi HanPei-Long ZhangYi-Long Wu
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
ex14-mutant NSCLC.
Keyphrases
  • advanced non small cell lung cancer
  • phase ii
  • epidermal growth factor receptor
  • clinical trial
  • open label
  • tyrosine kinase
  • double blind
  • cross sectional
  • phase iii
  • wild type